4.5 Review

Regulation of IGF-I function by proinflammatory cytokines: At the interface of immunology and endocrinology

期刊

CELLULAR IMMUNOLOGY
卷 252, 期 1-2, 页码 91-110

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.cellimm.2007.09.010

关键词

IGF-I; TNF alpha; IL-1 beta; innate immune system; resistance; receptor crosstalk; sickness behavior

资金

  1. National Institutes of Health [AI 50442, MH 51569, AG 029573, MH 07139, MH 079829, AG 023580, AG 16710]
  2. USDA [2004-35206-14144]
  3. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050442] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051569, R01MH071349, R01MH079829] Funding Source: NIH RePORTER
  5. NATIONAL INSTITUTE ON AGING [R01AG016710, R01AG029573, R01AG023580] Funding Source: NIH RePORTER

向作者/读者索取更多资源

During the past decade, the immune and endocrine systems have been discovered to interact in controlling physiologic processes as diverse as cell growth and differentiation, metabolism, and even human and animal behavior. The interaction between these two major physiological systems is a bi-directional process. While it has been well documented that hormones, including prolactin (PRL), growth hormone (GH), insulin-like growth factor-I (IGF-I), and thyroid-stimulating hormone (TSH), regulate a variety or immune events, a great deal of data have accumulated supporting the notion that cytokines from the innate immune system also affect the neuroendocrine system. Communication between these two systems coordinates processes that are necessary to maintain homeostasis. Proinflammatory cytokines often act as negative regulatory signals that temper the action of hormones and growth factors. This system of checks and balances' is an active, ongoing process, even in healthy individuals. Dysregulation of this process has been implicated as a potential pathogenic factor in the development of co-morbid conditions associated with several chronic inflammatory diseases, including type 2 diabetes, cardiovascular disease, cerebrovascular disease, inflammatory bowel disease, rheumatoid arthritis, major depression, and even normal aging. Over the past decade, research in our laboratory has focused on the ability of the major proinflammatory cytokines, tumor necrosis factor (TNF)alpha and interleukin (IL)-1 beta, to induce a state of IGF resistance. This review will highlight these and other new findings by explaining how proinflammatory cytokines induce resistance to the major growth factor, insulin-like growth factor-I (IGF-I). We also highlight that IGF-I can induce resistance or reduce sensitivity to brain TNF alpha and discuss how TNF-alpha, IL-1 beta. and IGF-I interact to regulate several aspects of behavior and cognition. (C) 2008 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据